Identification of the structural region of taxol that may be responsible for cytokine gene induction and cytotoxicity in human ovarian cancer cells

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 5, 1998, Pages 391-397

  Watson, Joanna M ^a   Kingston, David G I ^c   Chordia, Mahendra D ^c   Chaudhary, Ashok G ^c   Rinehart, Clifford A ^b   Haskill, J Stephen ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Analogs; Cytotoxicity; Gene induction; Human ovarian cancer; IL 8; Taxol

Indexed keywords

CYTOKINE; DOCETAXEL; INTERLEUKIN 8; PACLITAXEL; PACLITAXEL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENE INDUCTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; FEMALE; HUMANS; INTERLEUKIN-8; OVARIAN NEOPLASMS; PACLITAXEL; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031951005     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050756     Document Type: Article

References (34)

1. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55: 97
2. Braun RK, Franchini H, Erard F, Rihs S, DeVries IJ, Blaser K, Hansel TT, Walker C (1993) Human peripheral blood eosinophils produce and release IL-8 on stimulation with calcium ionophore. Eur J Immunol 23: 956
3. Schuerer-Maly C-C, Eckmann L, Kagnoff MF, Falco MT, Maly FE (1994) Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 81: 85
4. Singh RK, Gutman M, Radinsky R, Bucana CD, Fidler IJ (1994) Expression of IL-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res 54: 3242
5. Singh RK, Gutman M, Reich R, Bar-Eli M (1995) Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of IL-8. Cancer Res 55: 3669
6. Kock AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Elner SG, Strieter RM (1992) IL-8 as a macrophage-derived mediator of angiogenesis. Science 258: 1798
7. Smith DR, Polverini RJ, Kunkel SL, Orringer MB, Whyte RL, Burdick MD, Wilke CA, Strieter RM (1994) Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179: 1409
8. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334: 1
9. Lee L-F, Schuerer-Maly C-C, Lofquist AK, van Haaften-Day C, Ting JP-Y, White CM, Martin BK, Haskill JS (1996) Taxoldependent transcriptional activation of IL-8 expression in human ovarian cancer. Cancer Res 56: 1303
10. Gately DP, Sharma A, Christen RD, Howell SB (1996) Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153. Br J Cancer 73: 18
11. Vogel SN, Carboni JM, Manthey CL (1995) Paclitaxel, a mimetic of bacterial lipopolysaccharide (LPS) in murine macrophages. In: Georg GI, Chen TT, Ojima I, Vyas DM (eds) Taxane anticancer agents. Basic science and current status. (ACS Symposium series 583) American Chemical Society Press, Washington, DC p 162
12. Ding AH, Porteu F, Sanchez E, Nathan CF (1990) Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science 248: 370
13. O'Brien JM Jr, Wewers MD, Moore SA, Allen JN (1995) Taxol and colchicine increase LPS-induced pro-IL-1β production but do not increase IL-1β secretion. J Immunol 154: 4113
14. Manié S, Schmid-Alliana A, Kubar J, Ferrua B, Rossi B (1993) Disruption of microtubule network in human monocytes induces expression of interleukin-1 but not that of interleukin-6 nor tumor necrosis factor-α. J Biol Chem 268: 13675
15. WAF1 and p53 requires c-raf-1. Cancer Res 55: 4623
16. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325
17. Kingston DGI, Molinero AA, Rimoldi JM (1993) The taxane diterpenoids. In: Herz W, Kirby GW, Moore RE, Steglich W, Tamm C (eds) Progress in the chemistry of organic natural products, vol 61. Springer-Verlag, New York, pp 1-206
18. Burkhart CA, Berman JW, Swindell CS, Horowitz SB (1994) Relationship between the structure of taxol and other taxanes on induction of tumor necrosis factor-α and cytotoxicity. Cancer Res 54: 5779
19. Parness J, Kingston DGI, Powell RG, Harracksingh C, Horowitz SB (1982) Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem Biophys Res Commun 105: 1082
20. Samaranayake G, Magri NF, Jitrangsri C, Kingston DGI (1991) Modified taxols. 5. Reaction of taxol with electrophilic reagents and preparation of a rearranged taxol derivative with tubulin-assembly activity. J Org Chem 56: 5114
21. Chordia MD, Kingston DGI, Hamel E, Lin CM (1997) Synthesis and biological activity of A-norpaclitaxel analogs. Bioorg Med Chem 5: 941
22. Chaudhary AG, Chordia MD, Kingston DGI (1995) A novel benzoyl group migration: synthesis and biological evaluation of 1-benzoyl-2-des(benzoyloxy)paclitaxel. J Org Chem 60: 3260
23. Chaudhary AG, Rimoldi JM, Kingston DGI (1993) Modified taxols. 10. Preparation of 7-deoxytaxol, a highly bioactive taxol derivative, and interconversion of taxol and 7-epi-taxol. J Org Chem 58: 3298
24. Mangatal L, Adeline MT, Guénard D, Guéritte-Voegelein F, Potier P (1989) Application of the vicinal hydroxyamination reaction and asymmetric induction to the hemisynthesis of taxol and analogs. Tetrahedron 45: 4177
25. Grover S, Rimoldi JM, Molinero AA, Chaudhary AG, Kingston DGI, Hamel E (1995) Differential effects of paclitaxel (taxol) analogs modified at positions C-2, C-7 and C-3′ on tubulin polymerization and polymer stabilization: identification of a hyperactive paclitaxel derivative. Biochemistry 34: 3927
26. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 83: 55
27. Watson JM, Lofquist AK, Rinehart CA, Olsen JC, Makarov SS, Kaufman DG, Haskill JS (1995) The intracellular IL-1 receptor antagonist alters IL-1 inducible gene expression without blocking exogenous signaling by IL-1β. J Immunol 155: 4467
28. Kingston DGI, Samaranayake G, Ivey GA (1990) The chemistry of taxol, a clinically useful anticancer agent. J Nat Prod 53: 1
29. Lee L-F, Haskill JS, Mukaida N, Matsushima K, Ting JP-Y (1997) Identification of tumor-specific taxol responsive regulatory elements (TRRE) in the IL-8 promoter. Mol Cell Biol 17: 5097
30. Haskill S, Becker S, Fowler W, Walton L (1982) Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material. Br J Cancer 45: 728
31. Magri NF, Kingston DGI (1988) Modified taxols. 4. Synthesis and biological activity of taxols modified in the side chain. J Natl Prod 51: 298
32. Deutsch HM, Glinski JA, Hernandez M, Haugwitz RD, Narayanan VL, Suffness M, Zalkow LH (1989) Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity. J Med Chem 32: 788
33. Mathew AE, Majillano MR, Nath JP, Hines RH, Stella VJ (1992) Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J Med Chem 35: 145
34. Huizing MT, Sewberath Misser VH, Pieters RC, ten Bokkel Huinink WW, Veenhof CHN, Vermorken JB, Pinedo HM, Beijnen JH (1995) Taxanes: a new class of antitumor agents. Cancer Invest 13: 381